{"id":"NCT00619502","sponsor":"Sanofi Pasteur, a Sanofi Company","briefTitle":"Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants","officialTitle":"Immunogenicity and Safety Study of a Booster Dose of DTaP-IPV-Hep B-PRP~T Combined Vaccine at 15 to 18 Months of Age Following a Primary Series at 2, 3 and 4 Months of Age in Healthy Turkish Infants","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12","primaryCompletion":"2008-07","completion":"2008-07","firstPosted":"2008-02-21","resultsPosted":"2014-04-03","lastUpdate":"2016-05-13"},"enrollment":254,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Diphtheria","Polio","Pertussis","Hepatitis B"],"interventions":[{"type":"BIOLOGICAL","name":"DTaP-IPV-HB-PRP~T vaccine","otherNames":[]}],"arms":[{"label":"DTaP-IPV-Hep B-PRP~T Vaccine Group","type":"EXPERIMENTAL"},{"label":"Pentaxim™ + Engerix B™ Vaccines Group","type":"ACTIVE_COMPARATOR"}],"summary":"This is a follow-up of Study A3L10 (NCT00315055)\n\nImmunogenicity\n\n* To describe the antibody persistence following a primary series vaccination of either DTaP-IPV-HB-PRP\\~T or PENTAXIM™ and ENGERIX B®.\n* To describe the immunogenicity of a booster dose of DTaP-IPV-HB-PRP\\~T.\n\nSafety\n\n\\- To describe the safety profile after a booster dose of DTaP-IPV-HB-PRP\\~T.","primaryOutcome":{"measure":"Percentage of Participants With Pre-booster Antibody Persistence and Booster Response to DTaP-IPV-Hep B-PRP~T After Primary Vaccination With Either DTaP-IPV-Hep B-PRP~T or Pentaxim™ + Engerix B Vaccine™","timeFrame":"Day 0 before and Day 30 Post-booster vaccination","effectByArm":[{"arm":"DTaP-IPV-HepB-PRP~T","deltaMin":81,"sd":null},{"arm":"Pentaxim™ + Engerix B™","deltaMin":99,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":14},"locations":{"siteCount":1,"countries":["Turkey (Türkiye)"]},"refs":{"pmids":[],"seeAlso":["http://www.sanofipasteur.com"]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":130},"commonTop":["Injection site pain","Irritability","Injection site erythema","Anorexia","Pyrexia"]}}